ENLIVEN THERAPEUTICS INC (ELVN)

US29337E1029 - Common Stock

17.79  +0.61 (+3.55%)

After market: 17.65 -0.14 (-0.79%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
83.53M34.27M51.44M41.70M24.12M
Research and Development
64.57M18.94M38.44M32.15M19.01M
Selling, General, and Administrative Expenses
18.95M15.33M13.00M9.54M5.11M
Operating Income
-83.53M-34.27M-51.44M-41.70M-24.12M
Interest Income/Expense
11.97M940.00K230.00K480.00K580.00K
Other Income/Expense
-22.00K-100.00K-180.00K-150.00K80.00K
Non Recurring Items
N/A35.00MN/AN/AN/A
Income Before Taxes
-71.58M1.58M-51.38M-41.36M-23.46M
Income Tax
N/A90.00KN/AN/AN/A
Net Income
-71.58M1.49M-51.38M-49.22M-23.46M
EBITDA
-83.23M-33.66M-51.34M-41.60M-24.09M
 
Per Share Data
EPS Diluted Total Ops
-2.010.23-9.49-14.14-5.66
Non GAAP EPS
-2.19N/A-3.99-6.18N/A
 
Statistics

All data in USD

Charts